14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 ABEO stock ended at $4.56. This is 4.60% less than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 11.56% from a day low at $4.54 to a day high of $5.07.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Abeona Therapeutics Inc. prices

Date Open High Low Close Volume
Oct 05, 2021 $26.25 $26.75 $20.94 $23.76 154 794
Oct 04, 2021 $27.25 $27.75 $26.25 $26.25 20 496
Oct 01, 2021 $28.50 $28.50 $27.00 $27.50 16 333
Sep 30, 2021 $27.25 $28.38 $27.00 $28.00 16 131
Sep 29, 2021 $28.75 $29.25 $27.25 $27.50 31 078
Sep 28, 2021 $29.25 $29.50 $28.50 $28.50 14 809
Sep 27, 2021 $29.25 $29.88 $28.25 $29.50 30 205
Sep 24, 2021 $30.00 $30.50 $29.25 $29.50 17 293
Sep 23, 2021 $30.00 $30.50 $30.00 $30.50 7 602
Sep 22, 2021 $29.75 $31.00 $29.25 $29.75 21 571
Sep 21, 2021 $30.75 $30.75 $29.50 $30.25 12 368
Sep 20, 2021 $30.00 $30.50 $29.33 $30.25 15 109
Sep 17, 2021 $31.00 $31.75 $29.25 $30.00 34 626
Sep 16, 2021 $31.00 $31.75 $30.25 $31.00 14 861
Sep 15, 2021 $30.75 $31.75 $30.50 $31.00 13 651
Sep 14, 2021 $32.50 $32.50 $30.50 $30.50 21 271
Sep 13, 2021 $32.50 $32.75 $31.25 $32.00 21 067
Sep 10, 2021 $32.75 $33.00 $31.75 $32.25 8 732
Sep 09, 2021 $31.25 $33.25 $31.00 $32.50 17 700
Sep 08, 2021 $32.75 $32.75 $29.75 $31.25 33 454
Sep 07, 2021 $33.25 $34.00 $32.25 $32.25 26 648
Sep 03, 2021 $34.00 $34.00 $32.50 $33.75 9 013
Sep 02, 2021 $32.00 $34.00 $31.75 $33.75 25 544
Sep 01, 2021 $32.25 $33.13 $32.00 $32.25 17 986
Aug 31, 2021 $32.50 $33.25 $32.25 $33.00 17 760
Click to get the best stock tips daily for free!

About Abeona Therapeutics Inc.

Abeona Therapeutics. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;... ABEO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT